kinezodianone
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 5, 2022 (NCT05389267)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06394973 | Phase 2 | Aug 5, 2024 | Laboratoires Thea |
| NCT05389267 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2022 | Laboratoires Thea |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratoires Thea | For profit | 2 | 2 | 1 | 2022 |
1 organizations
Page 1 / 1